US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

J&J $5.5B Talc MDL Deal, $25.4M Cooley Judgment And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at Johnson & Johnson's $5.5 billion commitment in a proposed settlement to resolve thousands of suit... (more story)

This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca No Photo Available

Yeji Jesse Lee

Healthcare providers and drugmakers posted results for the second quarter of 2026 this past week, giving investors a closer look at ho... (more story)

340B Appellate Cases To Watch In The 2nd Half Of 2026 No Photo Available

Mark Payne

Drugmakers are pressing appellate judges in the back half of 2026 to strike down state laws blocking them from restricting 340B contra... (more story)